This task force joins together all WG3 participants actively working on MRI in transplant patients.
Renal transplant patients are likely to be excluded from CKD studies, and the potential of MRI biomarker in renal transplant patients needs to be investigated separately.
In addition, from a MRI technical perspective, it is quite a different area: protocols for native kidneys will not be optimal for transplants and vice versa, and MRI biomarker ranges could differ.
Main aims:
- To promote collaboration in the field of renal allograft MRI.
- To share retrospective data on post-transplant renal graft MRI in order to facilitate studies which explore the diagnostic potential of MRI for post-transplant complications.
- To promote applications for funding that supports pre-clinical and clinical research projects into the predictive and diagnostic potential of MRI sequences for pre-transplant (ex vivo) organ assessment and detecting and characterising post-transplant complications.
Recent advances:
- UMCG (Groningen, the Netherlands) and MHH (Hannover, Germany) drafted a grant proposal for the Dutch Kidney Foundation, for a study investigating the diagnostic potential of renal (graft) MRI for the detection and characterisation of post-transplant complications. Even if the proposal was rejected by the DKF, the groups involved in the project are looking for local financial resources to implement the project.
- The task force leads have asked the COST partners whether they would have relevant post-transplant renal (graft) MRI databases which could be shared, in order to retrospectively investigate the diagnostic potential of several sequences for post-transplant outcome and complications. So far, only few reactions were received, which were negative unfortunately. If you are willing to share post-transplant renal (graft) MRI data, please contact the task force leads
- Review article on renal graft MRI (Moers et al. MAGMA 2020; 33(1):49-61 )
Task force leads:
- Dr Cyril Moers
- Dr Ronald Borra
Groups involved :
| Center
|
People involved
|
Expertise
|
|---|---|---|
| Universitair Ziekenhuis Brussel, Belgium
|
Patricia van der Niepen
|
Nephrology
|
| Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech republic
|
Janka Slatinska
|
Nephrology
|
| Aarhus University Hospital, Denmark
|
Jens Dam Jensen
|
Nephrology
|
| Mansoura University, Egypt
|
Mohamed Abou El-Ghar
|
Radiology
|
| Centre Hospitalier Universitaire (CHU) de Bordeaux, France
|
Nicolas Grenier
|
Radiology
|
| Hannover Medical School, Germany
|
Katja Derlin
|
Radiology
|
| University of Duesseldorf, Germany
|
Alexandra Ljimani
|
Radiology
|
| University Medical Center Mannheim, Germany
|
Bernhard Kramer
|
Nephrology
|
| Charitè - Universitätsmedizin Berlin, Germany
|
Kai-Uwe Eckardt
|
Nephrology
|
| Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
|
Anna Caroli
|
MR imaging
|
| ASST Papa Giovanni XXIII, Bergamo, Italy
|
Piero Ruggenenti, Valentina Portalupi, Eliana Gotti
|
Nephrology
|
| University of Navarra, Pamplona, Spain
|
Maria Fernandez-Seara, Paloma Martin
|
Radiology, Nephrology
|
| Uppsala University, Sweden
|
Per Liss
|
Radiology
|
| Antaros Medical (SME), Sweden
|
Paul Hockings, Lisa Jarl
|
MR imaging, Clinical trials
|
| University of Lausanne, Switzerland
|
Menno Pruijm
|
Nephrology
|
| Freiburger Hospital (HFR), Switzerland
|
Harriet Thoeny
|
Radiology
|
| University of Geneve, Switzerland
|
Thomas De Perrot, Lena Berchtold
|
Radiology, Nephrology
|
| University Medical Center Groningen, the Netherlands
|
Cyril Moers, Ronald Borra
|
Nephrology, MR imaging
|
| University Medical Center Utrecht, the Netherlands
|
Arjen van Zuilen, Anneloes de Boer
|
Nephrology, Physiscs
|
| University of Glasgow, UK
|
Patrick Mark
|
Nephrology
|
| UCL Institute of Child Health, London, UK
|
Fabio Nery, Isky Gordon
|
MR physics, Radiology
|
| Cambridge University Hospitals NHS Foundation Trust, UK
|
Iosif Mendichovszky
|
Radiology
|
